Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding control in facelift surgery
ISRCTN17892023Phase 4Completed
- Sponsor
- King Saud University
- Start
- May 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid, lidocaine and epinephrine in postoperative hemorrhage, edema and ecchymosis (2 arms), sponsored by King Saud University. Primary endpoints: Intraoperative blood loss by suction volume, Intraoperative blood loss by gravimetric analysis and 4 more. Started May 2024; status: completed.
02
Drugs
tranexamic acidlidocaineepinephrine
03
Conditions
postoperative hemorrhageedemaecchymosis
Beyond the preview
Go deeper on ISRCTN17892023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17892023.